Healthcare company DexCom, Inc. (NASDAQ: DXCM) reported a double-digit increase in second-quarter earnings and also provided full-year guidance.
- Second-quarter revenue grew 25% year-over-year to $871.3 million, on a reported basis, and 26% on an organic basis
- U.S. revenue rose 21%; international revenue increased 38% on a reported basis and 40% on an organic basis
- Operating income increased sharply to $128.1 million in Q2 from $77.0 million in the prior-year quarter
- Q2 net income was $115.9 million or $0.28 per share, compared to $50.9 million or $0.12 per share in the same quarter of 2022
- As of June 30, Dexcom held $3.64 billion in cash, cash equivalents, and marketable securities
- For fiscal 2023, the management expects total revenue to be in the range of $3.500 billion to 3.550 billion, which represents a 20-22% growth
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
INTC Stock: Where does Intel stand in the semiconductor race?
Intel Corporation (NASDAQ: INTC) is working to regain dominance in the semiconductor market, while evolving from an integrated chipmaker into a global foundry player. The turnaround plan involves massive capital
J.M. Smucker (SJM) is prioritizing brands with the highest growth potential, a few points to note
Shares of The J.M. Smucker Co. (NYSE: SJM) dipped over 1% on Monday. The stock has dropped 13% over the past 12 months. The branded foods seller is operating in
Foxconn Technology reports a 22% surge in Q4 2025 revenue
Foxconn Technology Group, a key supplier for Apple Inc. (AAPL), announced financial results for the fourth quarter of fiscal 2025. Hon Hai Precision Industry Co., Foxconn's parent, said Q4 revenues increased
